Background Research evidence supports the efficacy of cognitive-behavioral therapy in the
treatment of drug-refractory positive symptoms of schizophrenia. Although the cumulative …

… schizophrenia, and were receiving antipsychotic medication, were each assessed by two
raters during the same examination period using the rating scale (Barnes & Halstead, 1988).…

Background Whether cannabis can cause psychotic or affective symptoms that persist beyond
transient intoxication is unclear. We systematically reviewed the evidence pertaining to …

Neuropsychological studies of patients with schizophrenia have consistently identified deficits
on tests sensitive to frontal lobe function. One paradigm that has been widely used is that …

BackgroundSubstance use may be a risk factor for the onset of schizophrenia.AimsTo examine
the association between substance use and age at onset in a UK, inner-city sample of …

BackgroundStudies in schizophrenia suggest that a longer initial period of untreated illness
is associated with a poorer clinical outcome.AimsTo determine whether, in first-episode …

Page 1 Taylor The new edition of the world-renowned referenceguideonthe use of medications
for patients presenting with mentalhealthproblems The Maudsley Prescribing Guidelines …

Context Second-generation (atypical) antipsychotics (SGAs) are more expensive than first-generation
(typical) antipsychotics (FGAs) but are perceived to be more effective, with fewer …

Akathisia is a syndrome of motor restlessness, principally seen in association with antipsychotic
medication. It is characterized by a subjective experience of mental unease and the urge …

OBJECTIVE: The authors performed a systematic review and meta-analysis of studies of the
potential of new-generation antipsychotic drugs to improve adherence and decrease …